HAN Ran, MA Tao, ZHANG Zhi-chen, et al. Experimental Research Progress of Dihuang Yinzi in Treatment of Alzheimer's Disease[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(21): 124-130.
DOI:
HAN Ran, MA Tao, ZHANG Zhi-chen, et al. Experimental Research Progress of Dihuang Yinzi in Treatment of Alzheimer's Disease[J]. Chinese journal of experimental traditional medical formulae, 2018, 24(21): 124-130. DOI: 10.13422/j.cnki.syfjx.20182141.
Experimental Research Progress of Dihuang Yinzi in Treatment of Alzheimer's Disease
Dihuang Yinzi comes from Huangdi Neijing·Suwen·Xuanming Lunfang
and consists of 15 herbs. The king herbs
including Cistanches Herba
Morindae Officinalis Radix
Rehmanniae Radix Praeparata
Corni Fructus
are capable of tonifying kidney-yin and nourishing the bone marrow. Ministerial herbs
including Aconiti Lateralis Radix Praeparaia
Cinnamomi Cortex
Ophiopogonis Radix
Dendrobii Caulis
Schisandrae Chinensis Fructus
could maintain vitality
nourish yin
and converge liquid. Adjuvant herbs
Polygalae Radix
Acori Tatarinowii Rhizoma
Poria have the functions of eliminating phlegm and inducing resuscitation. Conductant herbs
including Menthae Haplocalycis Herba
Zingiberis Rhizoma Recens
Jujubae Fructus could consolidate the vitality. Alzheimer's disease (AD) is a neurodegenerative disease and belongs to the category of dementia in Chinese medicine. The pathogenesis of AD is complex and involves multiple pathological processes. Since the onset of AD is occult
and the process is irreversible
AD has enormous damages and very high mortality and morbidity. Chinese herbal compounds based on traditional Chinese medicine(TCM) theory have unique advantages in the treatment of AD. Studies in recent years have shown that Dihuang Yinzi has definite curative effects in the treatment of AD
and its pharmacological mechanisms include multiple factors such as protection of mitochondria
improvement of energy metabolism
antioxidation
regulating the process of beta amyloid precursor protein (APP) and metabolism of amyloid β protein (Aβ)
anti-apoptosis
regulation of neurotransmitters
protection of synapses and anti-inflammatory effects. The recent research progress on pharmacological mechanism of Dihuang Yinzi for AD was reviewed in the present article.